follow up q. Which meds ?
Sep 4, 2007
thanks for your reply Doctor Young. I live in Asia , not the USA, so i am guessing that some of the new treatment released in the USA might not have reached asia yet ? obviousely i would much rather take fewer pills, once per day, instead of the 3 pills , twice per day (combivir & Kaletra) regimen that my doctor is suggesting . However, i guess i need to ask him whats avalailable. Do you have any knowledge / experience of dealing with this in Asia and which meds are avaiilable here ?
Thanks very much
Response from Dr. Young
Thanks for your follow up.
Different countries do indeed have different access to HIV medications. You say that you live in Asia, yet Asia is a very big place with many different medical situations. Without knowing which country you live in, I can't provide more specifics
All that said, know that the combo that your doctor has recommended for first-line would likely be a very good option- indeed, many of my patients have opted (even with all of our options in the US) to start with a boosted PI- similar to what your doctor has suggested.
Best of health, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Would Herpes Show On A Pap Smear If You Are Not Having A Breakout
- Worried About Hiv Can't Sleep Already Have Herpes
- Will I Be Okay Having Protected Sex With Hpv?
- What Is The Percentage For Positive Herpes Simplex Type 1?
- What Does It Mean To Have A Positive Hpv Blood Test?
- What Does Herpes Do To The Spine?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.